GLP Watchdog

Enhance MD vs Hims

Hims has an open FDA warning letter dated September 9, 2025. Enhance MD has none. No price lines up like for like: Enhance MD and Hims publish prices for different products.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Enhance MD / Hims

Featured pick (affiliate partner)

Enhance MD logo

Enhance MD

7.4/10

Hims logo

Hims

6.7/10

FDA warning letters
None on record
Pharmacy
Lowest standing price
$249/moCompounded semaglutide injection, billed every 4 weeks
$149/moBrand-name semaglutide pill, medication only, membership extra
States
40 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Enhance MDFull review
Visit HimsFull review

Enhance MD is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hims pays us nothing. The scores are computed the same way for both and are shown as computed (Enhance MD 7.4, Hims 6.7). How we are paid

What the record shows

  1. 01

    Hims has an open FDA warning letter dated September 9, 2025. Enhance MD has none.

  2. 02

    Enhance MD names five pharmacies, all 503A. Hims sells brand-name medication only.

  3. 03

    No price lines up like for like: Enhance MD and Hims publish prices for different products.

  4. 04

    Only Enhance MD lists a price for compounded semaglutide injection and compounded tirzepatide injection. Only Hims lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

  5. 05

    Hims covers 10 states Enhance MD does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Enhance MD

Hims

Compounded semaglutide injection

$249/mo

$3,237 a year, 13 charges

Not sold or not priced
Compounded tirzepatide injection

$329/mo

$4,277 a year, 13 charges

Not sold or not priced
Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Price includes
Medication, clinician visits, shipping, labs
Medication
Billed separately
Not stated
Clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None month to month; longer plans charge once per 12, 24 or 48 weeks
Monthly membership, auto-renews
Refunds
Full refund of the initial payment if found ineligible during onboarding; no returns on prescription products
First month's membership fee is non-refundable; partial-period refunds are not guaranteed
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Enhance MD: October 17, 2026. Hims: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Enhance MD

7.4/10
Featured pick (affiliate partner)
  • No FDA warning letter on record
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Hims does not price
  • Price includes clinician visits
Visit Enhance MD

The case for Hims

6.7/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Enhance MD does not price
  • Lists 50 states against 40
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
  • Lowest price covers the medication only, with a separate membership on top
Visit Hims

Scores

Enhance MD 7.4 · Hims 6.7 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

7.0A
vs
B
8.0

Trust & Safety15%

9.0A
vs
B
6.0

Accessibility10%

8.4A
vs
B
10.0

Support10%

8.5A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Enhance MD vs Hims: questions

Hims has an open FDA warning letter dated September 9, 2025. Enhance MD has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Enhance MD names five pharmacies, all 503A. Hims sells brand-name medication only. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like: Enhance MD and Hims publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Enhance MD states you can cancel at any time; refunds: full refund of the initial payment if found ineligible during onboarding; no returns on prescription products. Hims states you can cancel at any time; refunds: first month's membership fee is non-refundable; partial-period refunds are not guaranteed.
Enhance MD is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hims pays us nothing. The scores are computed the same way for both and are shown as computed (Enhance MD 7.4, Hims 6.7).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks